Agios Pharmaceuticals (AGIO) Q3 2021 Earnings

29JulConfirmed
Q4 2020
Q1 2021
Q2 2021
Q3 2021
-1.44
8.02
17.49
26.95

Details

Expected EPS
-1.39
Actual EPS
-1.44
Surprise EPS
-0.05
Surprise Percent
+3.6%

Description

Agios Pharmaceuticals (AGIO) has reported earnings of -1.44 per share for Q3 2021.

0 Comments

Share your thoughts